BioArctic AB Statistics

Total Valuation

BioArctic AB has a market cap or net worth of GBP 1.27 billion. The enterprise value is 1.21 billion.

Market Cap	1.27B
Enterprise Value	1.21B

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	74.13M
Shares Outstanding	n/a
Shares Change (YoY)	+0.36%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	53.15M

Valuation Ratios

The trailing PE ratio is 18.21 and the forward PE ratio is 18.92.

PE Ratio	18.21
Forward PE	18.92
PS Ratio	10.83
PB Ratio	8.49
P/TBV Ratio	8.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.35, with an EV/FCF ratio of -72.35.

EV / Earnings	17.39
EV / Sales	10.27
EV / EBITDA	16.35
EV / EBIT	16.94
EV / FCF	-72.35

Financial Position

The company has a current ratio of 13.39, with a Debt / Equity ratio of 0.03.

Current Ratio	13.39
Quick Ratio	5.21
Debt / Equity	0.03
Debt / EBITDA	0.05
Debt / FCF	-0.24
Interest Coverage	65.14

Financial Efficiency

Return on equity (ROE) is 61.64% and return on invested capital (ROIC) is 38.56%.

Return on Equity (ROE)	61.64%
Return on Assets (ROA)	35.28%
Return on Invested Capital (ROIC)	38.56%
Return on Capital Employed (ROCE)	46.65%
Revenue Per Employee	1.01M
Profits Per Employee	599,548
Employee Count	107
Asset Turnover	0.93
Inventory Turnover	n/a

Taxes

In the past 12 months, BioArctic AB has paid 2.47 million in taxes.

Income Tax	2.47M
Effective Tax Rate	3.43%

Stock Price Statistics

The stock price has decreased by -18.21% in the last 52 weeks. The beta is -0.74, so BioArctic AB's price volatility has been lower than the market average.

Beta (5Y)	-0.74
52-Week Price Change	-18.21%
50-Day Moving Average	186.51
200-Day Moving Average	188.14
Relative Strength Index (RSI)	51.56
Average Volume (20 Days)	4,394

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioArctic AB had revenue of GBP 117.00 million and earned 69.55 million in profits. Earnings per share was 0.78.

Revenue	117.00M
Gross Profit	114.21M
Operating Income	70.93M
Pretax Income	72.01M
Net Income	69.55M
EBITDA	72.43M
EBIT	70.93M
Earnings Per Share (EPS)	0.78

Full Income Statement

Balance Sheet

The company has 60.80 million in cash and 3.93 million in debt, giving a net cash position of 56.87 million.

Cash & Cash Equivalents	60.80M
Total Debt	3.93M
Net Cash	56.87M
Net Cash Per Share	n/a
Equity (Book Value)	149.12M
Book Value Per Share	1.68
Working Capital	144.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.66 million and capital expenditures -2.05 million, giving a free cash flow of -16.71 million.

Operating Cash Flow	-14.66M
Capital Expenditures	-2.05M
Free Cash Flow	-16.71M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 97.61%, with operating and profit margins of 60.62% and 59.44%.

Gross Margin	97.61%
Operating Margin	60.62%
Pretax Margin	61.55%
Profit Margin	59.44%
EBITDA Margin	61.91%
EBIT Margin	60.62%
FCF Margin	n/a

Dividends & Yields

BioArctic AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.36%
Shareholder Yield	n/a
Earnings Yield	5.49%
FCF Yield	-1.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4